MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) said today that during July, three additional medical centers in the US added its anti-clotting device.
The facilities are located in Virginia and Iowa.
MCS said that the three centers carry out about 2,500 medical procedures that are relevant for the use of its device, and that it estimates that it will reach a 25% penetration rate in the first year.
MCS's ActiveCare+SFT device is a non-invasive alternative to medication in preventing deep vein thrombosis in orthopedic surgery patients.
MCS CEO Adi Dagan said, "The increased interest in the solution offered by us allows us to increase our US penetration and to reach new medical centers each month. We are witnessing a growing trend of doctors preferring ActiveCare+SFT over medication, and believe the trend will continue to grow."
Shares in MCS rose 2.1% today. The shares have gained over 46% so far in 2010.
Published by Globes [online], Israel business news - www.globes-online.com - on August 3, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010